Want to join the conversation?
$CSL said it appointed Kevin Zdimal as VP of Business Development. Zdimal joined $CSL in 1995 and has worked in number of leadership roles at its corporate office and Interconnect Technologies division. Replacing Zdimal as CAO is Titus Ball, who has been with $CSL since 2010 in roles of Director of Internal Audit and Manager of SEC Reporting.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.